Advanced Ultrasound Imaging for Patients in Oncology: DCE-US

Area of Science:

• Oncology
• Vascular Biology
• Cancer Therapeutics

Background:

• Neovascularization is essential for tumor growth beyond a minimal size (2-3 mm³).
• Tumor angiogenesis, the formation of new blood vessels, supports malignancy progression.
• The development of new tumor vasculature is a critical hallmark of cancer.

Purpose of the Study:

• To highlight the significance of neovascularization in malignant growth.
• To emphasize neoangiogenesis as a key target for novel anticancer strategies.
• To underscore the importance of antiangiogenesis and antivascular treatments.

Main Methods:

• Literature review on tumor angiogenesis and its role in cancer progression.
• Analysis of existing and emerging antiangiogenesis and antivascular therapeutic approaches.
• Synthesis of information regarding the targeting of tumor vasculature.

Main Results:

• Neovascularization is a critical determinant for tumors to exceed 2-3 mm³.
• Neoangiogenesis represents a pivotal target for innovative anticancer treatments.
• Current research focuses on therapies designed to destroy or inhibit tumor vessel growth.

Conclusions:

• Targeting tumor neovascularization is a promising strategy in oncology.
• Antiangiogenesis and antivascular therapies are vital components of modern cancer treatment.
• Further research into modulating tumor angiogenesis holds significant therapeutic potential.